BGNE Insider Trading Activity and SEC Form 4 Filings
BGNE insider trading summary
No open-market insider purchases or sales of BeiGene, Ltd. (BGNE) have been reported on SEC Form 4 in the past 12 months.
Latest BGNE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 13, 2025 | Xiaodong Wang | Director | Sell | $4.7M (21,235 @ $223.41) |
| May 13, 2025 | Xiaodong Wang | Director | Sell | $2.3M (10,104 @ $224.32) |
| May 13, 2025 | Xiaodong Wang | Director | Sell | $2.3M (10,221 @ $222.83) |
| May 13, 2025 | Xiaodong Wang | Director | Sell | $45K (200 @ $225.68) |
| Apr 14, 2025 | Xiaodong Wang | Director | Sell | $192K (805 @ $238.48) |
| Apr 14, 2025 | Xiaodong Wang | Director | Sell | $691K (2,884 @ $239.51) |
| Apr 14, 2025 | Xiaodong Wang | Director | Sell | $1.6M (6,398 @ $243.41) |
| Apr 14, 2025 | Xiaodong Wang | Director | Sell | $538K (2,229 @ $241.51) |
| Apr 14, 2025 | Xiaodong Wang | Director | Sell | $236K (995 @ $237.56) |
| Apr 14, 2025 | Xiaodong Wang | Director | Sell | $133K (535 @ $248.90) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.